Back | Next |
home / stock / acad / acad message board
Subject | By | Source | When |
---|---|---|---|
Pretty standard stuff. Most Pharma companies have legal issues | LasNubes | investorshub | 11/23/2022 5:38:39 PM |
OK, that's good but what about this? | gi197845 | investorshub | 11/23/2022 3:15:07 PM |
$ACAD is the plaintiff and filed suit due | LasNubes | investorshub | 11/23/2022 11:58:37 AM |
Wow, yet another lawsuit! | gi197845 | investorshub | 11/23/2022 2:33:53 AM |
Uh oh, Acadia going out of business due | gi197845 | investorshub | 11/22/2022 11:39:39 PM |
Good pop today | harry crumb | investorshub | 11/11/2022 12:27:00 AM |
Things like that happen with bios, its still | harry crumb | investorshub | 08/09/2022 10:23:12 PM |
What about the latest shelf offering and the | gi197845 | investorshub | 08/09/2022 7:40:11 PM |
Ah listen pal, before u make a comment | harry crumb | investorshub | 08/09/2022 1:54:49 AM |
Big mistake listening to Harry Crumb! Keep in | gi197845 | investorshub | 08/05/2022 3:57:27 AM |
Acadia Pharmaceuticals Inc. (Nasdaq: $ACAD) today announced that | gi197845 | investorshub | 08/05/2022 3:21:10 AM |
Smell my shorts, shortie! In your face! | gi197845 | investorshub | 08/03/2022 4:30:22 PM |
State of New Jersey Common Pension Fund D | gi197845 | investorshub | 08/03/2022 2:52:27 PM |
I figured it out. The only reason why | gi197845 | investorshub | 08/02/2022 1:45:50 AM |
Hey foo, I hope your shorting this! | gi197845 | investorshub | 08/02/2022 1:23:49 AM |
I figured it out. The only reason why | gi197845 | investorshub | 08/02/2022 1:05:56 AM |
I agree, Trofinetide is a great, big and | gi197845 | investorshub | 07/21/2022 6:18:49 PM |
with an opened-shirt and flabby belly hanging out | IanFromSI | investorshub | 07/13/2022 5:52:37 PM |
And here's one from only 2 days ago... | IanFromSI | investorshub | 07/13/2022 5:42:00 PM |
- If you really need to go all | IanFromSI | investorshub | 07/13/2022 5:38:45 PM |
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
2024-06-26 17:30:03 ET BMO Capital analyst issues OUTPERFORM recommendation for ACAD on June 26, 2024 04:09PM ET. The previous analyst recommendation was Buy. ACAD was trading at $15.5 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...
2024-06-26 17:00:07 ET Keith Tapper from BMO Capital issued a price target of $31.00 for ACAD on 2024-06-26 16:09:00. The adjusted price target was set to $31.00. At the time of the announcement, ACAD was trading at $15.5. The overall price target consensus is at $26.25 ...
2024-06-19 14:02:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...